President Trump put pharmaceutical CEOs on notice, demanding they lower drug prices or he promised to get involved.  He penned a letter to 17 CEOs, in July, outlining what he wants from the pharma industry to cut expenses for consumers.In many cases, Americans are paying higher prices for drugs that treat common conditions, while customers in foreign countries pay less.  FOX Business takes a look at the top five most expensive drugs by sales in the U.S. and what they are likely to cost consumers out of pock ...

Third quarter revenue grew 28% year-over-year to $886 million Robust growth of larger customers, with about 4,060 $100k+ ARR customers, up from about 3,490 a year ago Reached a milestone of over 1,000 integrations on the Datadog unified platform NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Datadog, Inc. (NASDAQ:DDOG), the monitoring and security platform for cloud applications, today announced financial results for its third quarter ended September 30, 2025. "Datadog had a strong third quarter, with 28% year ...

Press ReleaseNokia Bell Labs and KDDI Research unite to drive innovation in 6G energy efficiency and network resiliency These two industry-leading research institutions are expanding their collaboration efforts to advance 6G technologies, setting the foundation for transformative connectivity solutions.The research collaboration will enable the commercialization of 6G networks that prioritize energy efficiency and resiliency. 6 November 2025Espoo, Finland – Nokia and KDDI Research have entered into a joint ...

MONTREAL, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Supremex Inc. (“Supremex” or the “Company”) (TSX: SXP), a leading North American manufacturer and marketer of envelopes and a growing provider of paper-based packaging solutions, today announced its results for the third quarter ended September 30, 2025. The Company will hold a conference call to discuss these results today at 10:00 a.m. (Eastern Time). Third Quarter Financial Highlights and Recent Events Total revenue of $65.7 million, versus $69.4 million in the ...

AppLovin ( APP ) released another strong quarter, which means that my previous calls questioning sustainability of growth and operating leverage did not age well. The share price is currentlyWith a decade at a Big 4 audit firm specializing in the banking, mining, and energy sectors, I bring a strong foundation in finance and strategy. Currently, I serve as the Head of Finance for a leading owner and operator of retail real estate, where I oversee complex financial operations and strategy. I’ve been an activ ...

Early momentum in tokenized gold market highlights growing appetite for trusted, asset-backed digital currenciesTrading volumes for gold averaged record US$329 billion per day during first half of 2025, demonstrating impact of digital innovations on market activityFirst Step in launching integrated ecosystem: "Mine-to-Wallet" NEW YORK, NY, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Blue Gold Limited (Nasdaq: BGL) (“Blue Gold” or the “Company”), a next-generation gold development and technology company, today annou ...

NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet mental health needs, today announced a major clinical milestone with multiple patients successfully dosed in its ongoing Phase IIb clinical trial evaluating nature-derived psilocybin, in combination with psychotherapy, as a potential treatment for Adjustment Disorder in palliative care. This ach ...

Reports Q3 2025 Revenues of $20.6M, Gross Margin of 58.4%, and Positive Cash Provided by OperationsCompany Expects to Refinance or Repay the Debt in the Fourth QuarterFourth Quarter 2025 Guidance Reflects Increased Demand and Backlog, Improved Operations and Strong Financial Discipline HOLLISTON, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the third quarter and nine months ended September 30, 2025. “Our third-quarter ...

Strong Cost Controls and Project Concord Aiding Performance Company Well Positioned to Capitalize on Industry Dislocation GARDEN CITY, N.Y., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Lifetime Brands, Inc. (NasdaqGS: LCUT), a leading global designer, developer and marketer of a broad range of branded consumer products used in the home, today reported its financial results for the quarter ended September 30, 2025. Rob Kay, Lifetime's Chief Executive Officer, commented, “While the current tariff environment has creat ...

Received CTA authorization for Phase 1 trial of lead program AX-0810, targeting NTCP for cholestatic diseasesInitiating Phase 1 study of AX-0810 in healthy volunteers, with initial safety, tolerability, and PK data from Cohort 1 expected by year-end, and target engagement data from all cohorts in H1 2026€ 106.9 million cash and cash equivalents as of end Q3 – providing runway into mid-2027 LEIDEN, Netherlands & CAMBRIDGE, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR ...